A rare spot on my Team has opened up. While it is our lead tech position, I'm open to hiring in at any skill level for the right applicant depending on experience and more importantly effort.

From expanding partnerships to advancing trials, Mainz Biomed NV MYNZ, the molecular genetics diagnostic company, had a busy 2024 – which appears to have shown in its revenue growth. The company ...

BERKELEY, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early ...

Mainz Biomed NV是一家德国的分子遗传学癌症诊断公司。该公司经营一个部门，即基因诊断检测部门。其产品组合包括各种产品和候选产品，例如结肠直肠癌(CRC)筛查粪便 DNA（脱氧核糖核酸）测试产品ColoAlert、用于检测胰腺癌的粪便筛查测试产品PancAlert及基于分子 ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development ...

New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) (“Psyence BioMed” or the “Company”) today announced a strategic follow-on investment of USD $500,000 into ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Orchestra BioMed Holdings, Inc. before investing. In this article, we go over a ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...